Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.40 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22554699 | 0.86 | ALDH1A1 (0.67) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL1392591 | 0.85 | CYP3A4 (0.65) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL3827276 | 0.83 | ESR2 (0.50) | ALDH1A1CYP3A4TDP1TSHRESR2 | |
| SCHEMBL807863 | 0.83 | ALDH1A1 (0.70) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL22554727 | 0.81 | ALDH1A1 (0.67) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL22554778 | 0.78 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL1918559 | 0.78 | ALDH1A1 (0.54) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL8954034 | 0.76 | ALDH1A1 (0.82) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL22517389 | 0.76 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL7246163 | 0.76 | CYP2A6 (0.46) | ALDH1A1CYP3A4TDP1ESR2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111825558-B | Novel compound and organic light-emitting device | 乐金显示有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| CN-111825558-A | Novel compound and organic light-emitting device | 乐金显示有限公司 | 2020-10-27 | — | — | CN | disclosed |
| US-20200335698-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO., LTD. (KR) | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11844270-B2 | Compound and organic light emitting device including the same | TMEM109, CRY1, VDAC1 | ALDH1A1 54/4885CYP3A4 212/4885TDP1 1190/4885 |
| US-20200335698-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | TMEM109, TRPC1, MAP1LC3B | ALDH1A1 155/4885CYP3A4 436/4885TDP1 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.